ArticleImmune network2021

Tumor-Infiltrating Neutrophils and Non-Classical Monocytes May Be Potential Therapeutic Targets for HER2

Juhee Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.